Suchergebnisse - "Davies, Jane C"

PubPharm (69)

1

Cystic Fibrosis : From Salty Malediction to Possible Cure

enthalten in: Archivos de bronconeumologia | 2024

von Sole, A. | Davies, J. | Quintana-Gallego, E.

2

Standards for the care of people with cystic fibrosis; establishing and maintaining health

enthalten in: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society | 2024

von Southern, K. | Addy, C. | Bell, S. | +41

3

Standards for the care of people with cystic fibrosis (CF)

enthalten in: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society | 2023

von Southern, K. | Burgel, P. | Castellani, C. | +9

4

Improvement in Lung Clearance Index and Chest Computed Tomography Scores with Elexacaftor/Tezacaftor/Ivacaftor Treatment in People with Cystic Fibrosis Aged 12 Years and Older - The RECOVER Trial

enthalten in: American journal of respiratory and critical care medicine | 2023

von McNally, P. | Lester, K. | Stone, G. | +25

CommentIn: Am J Respir Crit Care Med. 2023 Nov 1;208(9):911-913. - PMID 37756441

5

Advancing the pipeline of cystic fibrosis clinical trials : a new roadmap with a global trial network perspective

enthalten in: The Lancet. Respiratory medicine | 2023

von Mayer-Hamblett, N. | Clancy, J. | Jain, R. | +23

6

The clinical impact of Lumacaftor-Ivacaftor on structural lung disease and lung function in children aged 6-11 with cystic fibrosis in a real-world setting

enthalten in: Respiratory research | 2023

von McNally, P. | Linnane, B. | Williamson, M. | +9

7

Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged ⩾6 Years with Cystic Fibrosis and at Least One F508del Allele : A Phase 3, Open-Label Clinical Trial

enthalten in: American journal of respiratory and critical care medicine | 2023

von Wainwright, C. | McColley, S. | McNally, P. | +14

CommentIn: Am J Respir Crit Care Med. 2023 Jul 1;208(1):9-11. - PMID 37167625

8

Raised Intracranial Pressure in Three Children with Cystic Fibrosis Receiving Elexacaftor-Tezacaftor-Ivacaftor Modulator Therapy

enthalten in: American journal of respiratory and critical care medicine | 2023

von Southern, K. | Barben, J. | Goldring, S. | +5

9

Future therapies for cystic fibrosis

enthalten in: Nature communications | 2023

von Allen, L. | Allen, L. | Carr, S. | +10

10

Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for F508del and a Minimal Function Mutation : A Phase 3b, Randomized, Placebo-controlled Study

enthalten in: American journal of respiratory and critical care medicine | 2022

von Mall, M. | Brugha, R. | Gartner, S. | +21

CommentIn: Am J Respir Crit Care Med. 2022 Dec 1;206(11):1308-1310. - PMID 35947636

1
2
3
4
5
6
7
Nächster »
[7]